# Vitalgen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vitalgen

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.vitalgen.com/
- Latest round: Series B (Apr 20, 2025)
- Investors on record: 12

## About

Founded in 2020 and based in Shanghai, China, Shanghai Vitalgen BioPharma Co., Ltd., trading as Vitalgen, specializes in pioneering gene therapy solutions. In September 2025, the firm closed a round of venture funding from Cinda Capital, Maotian Capital, and Shanghai Xuhui Venture Capital.

Vitalgen develops advanced gene delivery and editing technologies aimed at treating various genetic and neurodegenerative disorders. Its core products include ViVec® AAV vector technology, ViLNP® lipid nanoparticle technology, and ViCas® CRISPR gene editing technology. The company is actively advancing multiple products into clinical research, targeting global markets for diseases such as AADC deficiency and amyotrophic lateral sclerosis (ALS).

The company generates revenue from partnerships and collaborations with biopharmaceutical companies, alongside direct sales of its gene therapy products. 

The company plans to launch additional innovative gene therapies and aims to penetrate broader geographic regions beyond China, enhancing its global reach in the gene therapy sector.

## Funding rounds

- Series B, Apr 20, 2025 — Loyal Valley Capital, CCB Private Equity Investment Management
- Series B, Aug 13, 2023 — In Capital, Shanghai Sci-Tech Innovation Center Capital
- Series B, Mar 2, 2023 — China Merchants Venture Investment Management
- Series A, Oct 14, 2021 — Cenova Ventures, Linchuang Capital, GL Ventures
- Series A, May 24, 2021 — IDG Capital, Loyal Valley Capital, Jifeng Ventures
- Angel, Jul 15, 2020 — IDG Capital, Apricot Capital, Jiupai Capital, Jifeng Ventures

## Investors

- IDG Capital (https://capitalatlas.ai/funds/idg-capital) — Angel, Series A
- Apricot Capital (https://capitalatlas.ai/funds/apricot-capital) — Angel
- Jiupai Capital — Angel
- Jifeng Ventures (https://capitalatlas.ai/funds/jifeng-ventures) — Angel, Series A
- Loyal Valley Capital (https://capitalatlas.ai/funds/loyal-valley-capital) — Series A, Series B
- Cenova Ventures (https://capitalatlas.ai/funds/cenova-ventures) — Series A
- Linchuang Capital (https://capitalatlas.ai/funds/linchuang-capital) — Series A
- GL Ventures (https://capitalatlas.ai/funds/gl-ventures) — Series A
- China Merchants Venture Investment Management (https://capitalatlas.ai/funds/china-merchants-venture-investment-management) — Series B
- In Capital — Series B
- Shanghai Sci-Tech Innovation Center Capital (https://capitalatlas.ai/funds/shanghai-sci-tech-innovation-center-capital) — Series B
- CCB Private Equity Investment Management (https://capitalatlas.ai/funds/ccb-private-equity-investment-management) — Series B